🚀 VC round data is live in beta, check it out!

Procter & Gamble Hygiene Valuation Multiples

Discover revenue and EBITDA valuation multiples for Procter & Gamble Hygiene and similar public comparables like Proya Cosmetics, Hengan Group, Fielmann Group, Giant Biogene and more.

Procter & Gamble Hygiene Overview

About Procter & Gamble Hygiene

Procter & Gamble Hygiene and Health Care Ltd is an Indian company engaged in the manufacturing and selling of feminine hygiene care and healthcare products. The portfolio includes brands like Ambi Pur, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide Ariel, Duracell, Gillette, Vicks, and Wella. The business is divided into a feminine hygiene business and a healthcare business. The feminine hygiene business offers sanitary napkins and feminine sanitary hygiene products; its popular brand is Whisper. The healthcare business offers creams, cough drops, and other health products. The company distributes its products through various channels: from retail locations such as mass merchandizers and grocery stores, to drug stores and department stores.


Founded

1964

HQ

India

Employees

421

Website

in.pg.com

Financials (LTM)

Revenue: $482M
EBITDA: $126M

EV

$4B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Procter & Gamble Hygiene Financials

Procter & Gamble Hygiene reported last 12-month revenue of $482M and EBITDA of $126M.

In the same LTM period, Procter & Gamble Hygiene generated $290M in gross profit, $126M in EBITDA, and $94M in net income.

Revenue (LTM)


Procter & Gamble Hygiene P&L

In the most recent fiscal year, Procter & Gamble Hygiene reported revenue of $501M and EBITDA of $117M.

Procter & Gamble Hygiene expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Procter & Gamble Hygiene forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$482MXXX$501MXXXXXXXXX
Gross Profit$290MXXX$210MXXXXXXXXX
Gross Margin60%XXX42%XXXXXXXXX
EBITDA$126MXXX$117MXXXXXXXXX
EBITDA Margin26%XXX23%XXXXXXXXX
EBIT Margin25%XXX22%XXXXXXXXX
Net Profit$94MXXX$83MXXXXXXXXX
Net Margin19%XXX17%XXXXXXXXX

Financial data powered by Morningstar, Inc.

Procter & Gamble Hygiene Stock Performance

Procter & Gamble Hygiene has current market cap of $4B, and enterprise value of $4B.

Market Cap Evolution


Procter & Gamble Hygiene's stock price is $124.67.

See Procter & Gamble Hygiene trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$4B0.4%XXXXXXXXX$2.55

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Procter & Gamble Hygiene Valuation Multiples

Procter & Gamble Hygiene trades at 8.2x EV/Revenue multiple, and 31.3x EV/EBITDA.

See valuation multiples for Procter & Gamble Hygiene and 15K+ public comps

EV / Revenue (LTM)


Procter & Gamble Hygiene Financial Valuation Multiples

As of March 7, 2026, Procter & Gamble Hygiene has market cap of $4B and EV of $4B.

Equity research analysts estimate Procter & Gamble Hygiene's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Procter & Gamble Hygiene has a P/E ratio of 43.2x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$4BXXX$4BXXXXXXXXX
EV (current)$4BXXX$4BXXXXXXXXX
EV/Revenue8.2xXXX7.9xXXXXXXXXX
EV/EBITDA31.3xXXX33.8xXXXXXXXXX
EV/EBIT32.5xXXX36.1xXXXXXXXXX
EV/Gross Profit13.6xXXX18.8xXXXXXXXXX
P/E43.2xXXX48.9xXXXXXXXXX
EV/FCF43.1xXXX65.8xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Procter & Gamble Hygiene Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Procter & Gamble Hygiene Margins & Growth Rates

Procter & Gamble Hygiene's revenue in the last 12 month grew by 8%.

Procter & Gamble Hygiene's revenue per employee in the last FY averaged $1.1M.

Procter & Gamble Hygiene's rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Procter & Gamble Hygiene's rule of X is 46% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Procter & Gamble Hygiene and other 15K+ public comps

Procter & Gamble Hygiene Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth8%XXX(4%)XXXXXXXXX
EBITDA Margin26%XXX23%XXXXXXXXX
EBITDA Growth10%XXX8%XXXXXXXXX
Rule of 40—XXX34%XXXXXXXXX
Bessemer Rule of X—XXX46%XXXXXXXXX
Revenue per Employee—XXX$1.1MXXXXXXXXX
S&M Expenses to Revenue—XXX11%XXXXXXXXX
G&A Expenses to Revenue—XXX0%XXXXXXXXX
Opex to Revenue—XXX23%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Procter & Gamble Hygiene Public Comps

See public comps and valuation multiples for other Health & Beauty comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Proya CosmeticsXXXXXXXXXXXXXXXXXX
Hengan GroupXXXXXXXXXXXXXXXXXX
Fielmann GroupXXXXXXXXXXXXXXXXXX
Giant BiogeneXXXXXXXXXXXXXXXXXX
Rohto PharmaceuticalXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Procter & Gamble Hygiene M&A Activity

Procter & Gamble Hygiene acquired XXX companies to date.

Last acquisition by Procter & Gamble Hygiene was on XXXXXXXX, XXXXX. Procter & Gamble Hygiene acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Procter & Gamble Hygiene

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Procter & Gamble Hygiene Investment Activity

Procter & Gamble Hygiene invested in XXX companies to date.

Procter & Gamble Hygiene made its latest investment on XXXXXXXX, XXXXX. Procter & Gamble Hygiene invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Procter & Gamble Hygiene

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Procter & Gamble Hygiene

When was Procter & Gamble Hygiene founded?Procter & Gamble Hygiene was founded in 1964.
Where is Procter & Gamble Hygiene headquartered?Procter & Gamble Hygiene is headquartered in India.
How many employees does Procter & Gamble Hygiene have?As of today, Procter & Gamble Hygiene has over 421 employees.
Is Procter & Gamble Hygiene publicly listed?Yes, Procter & Gamble Hygiene is a public company listed on National Stock Exchange of India.
What is the stock symbol of Procter & Gamble Hygiene?Procter & Gamble Hygiene trades under PGHH ticker.
When did Procter & Gamble Hygiene go public?Procter & Gamble Hygiene went public in 2004.
Who are competitors of Procter & Gamble Hygiene?Procter & Gamble Hygiene main competitors are Proya Cosmetics, Hengan Group, Fielmann Group, Giant Biogene.
What is the current market cap of Procter & Gamble Hygiene?Procter & Gamble Hygiene's current market cap is $4B.
What is the current revenue of Procter & Gamble Hygiene?Procter & Gamble Hygiene's last 12 months revenue is $482M.
What is the current revenue growth of Procter & Gamble Hygiene?Procter & Gamble Hygiene revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Procter & Gamble Hygiene?Current revenue multiple of Procter & Gamble Hygiene is 8.2x.
Is Procter & Gamble Hygiene profitable?Yes, Procter & Gamble Hygiene is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Procter & Gamble Hygiene?Procter & Gamble Hygiene's last 12 months EBITDA is $126M.
What is Procter & Gamble Hygiene's EBITDA margin?Procter & Gamble Hygiene's last 12 months EBITDA margin is 26%.
What is the current EV/EBITDA multiple of Procter & Gamble Hygiene?Current EBITDA multiple of Procter & Gamble Hygiene is 31.3x.
What is the current FCF of Procter & Gamble Hygiene?Procter & Gamble Hygiene's last 12 months FCF is $92M.
What is Procter & Gamble Hygiene's FCF margin?Procter & Gamble Hygiene's last 12 months FCF margin is 19%.
What is the current EV/FCF multiple of Procter & Gamble Hygiene?Current FCF multiple of Procter & Gamble Hygiene is 43.1x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial